María Lourdes
Vázquez López
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (9)
2021
-
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper
Infection, Vol. 49, Núm. 2, pp. 215-231
-
The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain
Mycoses, Vol. 64, Núm. 1, pp. 66-77
2019
-
Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH)
European Journal of Haematology, Vol. 102, Núm. 6, pp. 465-471
2017
-
Posicionamiento y actitudes de manejo sobre la profilaxis antifúngica en el paciente hematológico (proyecto PROMIC)
Revista Espanola de Quimioterapia, Vol. 30, Núm. 3, pp. 213-223
2016
2012
-
Effect of posaconazole on cyclosporine blood levels and dose adjustment in allogeneic blood and marrow transplant recipients
Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 12, pp. 6422-6424
2010
2006
-
Severe Infections after Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation in Adults: Comparison of Cord Blood Transplantation with Peripheral Blood and Bone Marrow Transplantation
Biology of Blood and Marrow Transplantation, Vol. 12, Núm. 7, pp. 734-748
2005
-
Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning
Biology of Blood and Marrow Transplantation, Vol. 11, Núm. 6, pp. 437-447